LNCARSR and renal cell carcinoma: For example, lncARSR promotes sunitinib resistance via competitively binding miR‐34/miR‐449 to facilitate AXL and c‐MET expression in renal cell carcinoma (RCC) cells, and intercellular transfer of lncARSR by exosomes disseminated sunitinib resistance.